{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:29:36Z","timestamp":1776310176648,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.omto.2021.12.004","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T01:58:54Z","timestamp":1638755934000},"page":"180-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Adenoviral delivery of an immunomodulatory protein to the tumor microenvironment controls tumor growth"],"prefix":"10.1016","volume":"24","author":[{"given":"Patrick","family":"O'Connell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-846X","authenticated-orcid":false,"given":"Maja K.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliya","family":"Pepelyayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6993-3795","authenticated-orcid":false,"given":"Sean","family":"Hyslop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Godbehere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana M.","family":"Angarita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane","family":"Pereira-Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Amalfitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9560-8013","authenticated-orcid":false,"given":"Yasser A.","family":"Aldhamen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2021.12.004_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: microenvironment-targeting combinations","volume":"30","author":"Murciano-Goroff","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.omto.2021.12.004_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T\u00a0cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1158\/2326-6066.CIR-18-0487","article-title":"The balancing act between cancer immunity and autoimmunity in response to immunotherapy","volume":"6","author":"Young","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omto.2021.12.004_bib4","doi-asserted-by":"crossref","first-page":"100738","DOI":"10.1016\/j.tranon.2019.12.010","article-title":"Resistance to checkpoint inhibition in cancer immunotherapy","volume":"13","author":"Barrueto","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.omto.2021.12.004_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics8040076","article-title":"Retrospective side effect profiling of the metastatic melanoma combination therapy ipilimumab-nivolumab using adverse event data","volume":"8","author":"Soldatos","year":"2018","journal-title":"Diagnostics"},{"key":"10.1016\/j.omto.2021.12.004_bib6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00262-013-1400-3","article-title":"Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients","volume":"62","author":"Morse","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.omto.2021.12.004_bib7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.omtm.2019.11.001","article-title":"Immunology of adenoviral vectors in cancer therapy","volume":"15","author":"Shaw","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omto.2021.12.004_bib8","article-title":"SLAMF7 is a critical negative regulator of IFN-alpha-Mediated CXCL10 production in chronic HIV infection","author":"O'Connell","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib9","article-title":"SLAM family receptor signaling in viral infections: HIV and beyond","volume":"7","author":"O'Connell","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omto.2021.12.004_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4049\/jimmunol.2000300","article-title":"SLAMF7 signaling reprograms T\u00a0cells toward exhaustion in the tumor microenvironment","volume":"206","author":"O'Connell","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1084\/jem.20132038","article-title":"EAT-2, a SAP-like adaptor, controls NK cell activation through phospholipase Cgamma, Ca++, and Erk, leading to granule polarization","volume":"211","author":"Perez-Quintero","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omto.2021.12.004_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ni.1693","article-title":"Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function","volume":"10","author":"Cruz-Munoz","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00011-013-0632-1","article-title":"CS1 (SLAMF7) inhibits production of proinflammatory cytokines by activated monocytes","volume":"62","author":"Kim","year":"2013","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.omto.2021.12.004_bib14","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/j.vaccine.2016.04.068","article-title":"CRACC-targeting Fc-fusion protein induces activation of NK cells and DCs and improves T\u00a0cell immune responses to antigenic targets","volume":"34","author":"Aldhamen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.omto.2021.12.004_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2165\/00003088-199528020-00004","article-title":"Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions","volume":"28","author":"Reilly","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.omto.2021.12.004_bib16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/07853890802698842","article-title":"Challenges in monoclonal antibody-based therapies","volume":"41","author":"Samaranayake","year":"2009","journal-title":"Ann. Med."},{"key":"10.1016\/j.omto.2021.12.004_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2021.12.004_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","article-title":"Innate immune response in Th1- and Th2-dominant mouse strains","volume":"22","author":"Watanabe","year":"2004","journal-title":"Shock"},{"key":"10.1016\/j.omto.2021.12.004_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental relationships of four exhausted CD8(+) T\u00a0cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.omto.2021.12.004_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omto.2021.12.004_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-immunol-030409-101302","article-title":"SLAM family receptors and SAP adaptors in immunity","volume":"29","author":"Cannons","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.1002105","article-title":"Expression of the SLAM family of receptors adapter EAT-2 as a novel strategy for enhancing beneficial immune responses to vaccine antigens","volume":"186","author":"Aldhamen","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s42256-020-00232-8","article-title":"Integration of mechanistic immunological knowledge into a machine learning pipeline improves predictions","volume":"2","author":"Culos","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.omto.2021.12.004_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-gamma in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.omto.2021.12.004_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.omto.2021.12.004_bib26","doi-asserted-by":"crossref","first-page":"14655","DOI":"10.1038\/s41598-017-14709-x","article-title":"Precision targeting of tumor macrophages with a CD206 binding peptide","volume":"7","author":"Scodeller","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omto.2021.12.004_bib27","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-18-2076","article-title":"Tumor-associated macrophages as prognostic and predictive biomarkers for postoperative adjuvant chemotherapy in patients with stage II colon cancer","volume":"25","author":"Feng","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2021.12.004_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cdd.2014.134","article-title":"New insights into IL-12-mediated tumor suppression","volume":"22","author":"Tugues","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omto.2021.12.004_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.it.2012.10.004","article-title":"Type I interferon response and innate immune sensing of cancer","volume":"34","author":"Fuertes","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib30","doi-asserted-by":"crossref","first-page":"e1314424","DOI":"10.1080\/2162402X.2017.1314424","article-title":"Type-I-interferons in infection and cancer: unanticipated dynamics with therapeutic implications","volume":"6","author":"Musella","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.omto.2021.12.004_bib31","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.4049\/jimmunol.178.7.4498","article-title":"IL-12 and type-I IFN synergize for IFN-gamma production by CD4 T\u00a0cells, whereas neither are required for IFN-gamma production by CD8 T\u00a0cells after Listeria monocytogenes infection","volume":"178","author":"Way","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1471-4906(00)01824-X","article-title":"IL-12 gene therapy for cancer: in synergy with other immunotherapies","volume":"22","author":"Melero","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","article-title":"Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history","volume":"19","author":"Fitzgerald-Bocarsly","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.omto.2021.12.004_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113285","article-title":"The immune checkpoint PD-1 in natural killer cells: expression, function and targeting in tumour immunotherapy","volume":"12","author":"Quatrini","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2021.12.004_bib35","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.cell.2017.04.016","article-title":"An immune atlas of clear cell renal cell carcinoma","volume":"169","author":"Chevrier","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.omto.2021.12.004_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nprot.2009.4","article-title":"A rapid protocol for construction and production of high-capacity adenoviral vectors","volume":"4","author":"Jager","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omto.2021.12.004_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/intimm\/dxt061","article-title":"Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy","volume":"26","author":"Aldhamen","year":"2014","journal-title":"Int. Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib38","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood.V96.5.1857","article-title":"Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in\u00a0vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses","volume":"96","author":"Herr","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.omto.2021.12.004_bib39","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1501272","article-title":"In\u00a0vivo Synthesis of cyclic-di-GMP using a recombinant adenovirus preferentially improves adaptive immune responses against extracellular antigens","author":"Alyaqoub","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cels.2018.02.010","article-title":"Compensation of signal spillover in suspension and imaging mass cytometry","volume":"6","author":"Chevrier","year":"2018","journal-title":"Cell Syst."},{"key":"10.1016\/j.omto.2021.12.004_bib41","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4049\/jimmunol.1200736","article-title":"Vaccines expressing the innate immune modulator EAT-2 elicit potent effector memory T lymphocyte responses despite pre-existing vaccine immunity","volume":"189","author":"Aldhamen","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omto.2021.12.004_bib42","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1038\/s41467-019-12235-0","article-title":"Functional interpretation of single cell similarity maps","volume":"10","author":"DeTomaso","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omto.2021.12.004_bib43","doi-asserted-by":"crossref","first-page":"e9579","DOI":"10.1371\/journal.pone.0009579","article-title":"A new adenovirus based vaccine vector expressing an Eimeria tenella derived TLR agonist improves cellular immune responses to an antigenic target","volume":"5","author":"Appledorn","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.omto.2021.12.004_bib44","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1182\/blood-2010-03-276949","article-title":"Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in\u00a0vitro and in\u00a0vivo","volume":"116","author":"Seregin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omto.2021.12.004_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.virusres.2009.10.023","article-title":"beta-Arrestins modulate Adenovirus-vector-induced innate immune responses: differential regulation by beta-arrestin-1 and beta-arrestin-2","volume":"147","author":"Seregin","year":"2010","journal-title":"Virus Res."},{"key":"10.1016\/j.omto.2021.12.004_bib46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/CVI.00341-10","volume":"18","author":"Appledorn","year":"2011","journal-title":"Clin. Vaccine Immunol."}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237277052100173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237277052100173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:26:00Z","timestamp":1762496760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S237277052100173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":46,"alternative-id":["S237277052100173X"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2021.12.004","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenoviral delivery of an immunomodulatory protein to the tumor microenvironment controls tumor growth","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}